Anti-™EM38A monoclonal antibody

Pre-made anti-™EM38A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM38A/™EM38A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2096-Ab-1/ GM-Tg-hg-IP2096-Ab-2Anti-Human ™EM38A monoclonal antibodyHuman
GM-Tg-rg-IP2096-Ab-1/ GM-Tg-rg-IP2096-Ab-2Anti-Rat ™EM38A monoclonal antibodyRat
GM-Tg-mg-IP2096-Ab-1/ GM-Tg-mg-IP2096-Ab-2Anti-Mouse ™EM38A monoclonal antibodyMouse
GM-Tg-cynog-IP2096-Ab-1/ GM-Tg-cynog-IP2096-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM38A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2096-Ab-1/ GM-Tg-felg-IP2096-Ab-2Anti-Feline ™EM38A monoclonal antibodyFeline
GM-Tg-cang-IP2096-Ab-1/ GM-Tg-cang-IP2096-Ab-2Anti-Canine ™EM38A monoclonal antibodyCanine
GM-Tg-bovg-IP2096-Ab-1/ GM-Tg-bovg-IP2096-Ab-2Anti-Bovine ™EM38A monoclonal antibodyBovine
GM-Tg-equg-IP2096-Ab-1/ GM-Tg-equg-IP2096-Ab-2Anti-Equine ™EM38A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2096-Ab-1/ GM-Tg-hg-IP2096-Ab-2; GM-Tg-rg-IP2096-Ab-1/ GM-Tg-rg-IP2096-Ab-2;
GM-Tg-mg-IP2096-Ab-1/ GM-Tg-mg-IP2096-Ab-2; GM-Tg-cynog-IP2096-Ab-1/ GM-Tg-cynog-IP2096-Ab-2;
GM-Tg-felg-IP2096-Ab-1/ GM-Tg-felg-IP2096-Ab-2; GM-Tg-cang-IP2096-Ab-1/ GM-Tg-cang-IP2096-Ab-2;
GM-Tg-bovg-IP2096-Ab-1/ GM-Tg-bovg-IP2096-Ab-2; GM-Tg-equg-IP2096-Ab-1/ GM-Tg-equg-IP2096-Ab-2
Products NameAnti-™EM38A monoclonal antibody
Formatmab
Target Name™EM38A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM38A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2096-Ag-1Recombinant multi-species ™38A/ ™EM38A/ TRIC-A protein


    Target information

    Target IDGM-IP2096
    Target Name™EM38A
    Gene ID79041,74166,306327,719600,610207,101080515,532775,100069904
    Gene Symbol and Synonyms1110001E17Rik,mg33a,RGD1307901,SPR-27,Srp-27,™EM38A,TRIC-A,TRICA
    Uniprot AccessionQ9H6F2,A6ZIQ8,A4FV75
    Uniprot Entry Name™38A_HUMAN,™38A_RAT,™38A_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000072954
    Target ClassificationN/A

    The target: ™EM38A, gene name: ™EM38A, also named as TRIC-A, TRICA. Predicted to enable potassium channel activity. Predicted to act upstream of or within several processes, including cellular response to caffeine; inorganic cation transmembrane transport; and regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.